promethazine has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 6 studies
Promethazine: A phenothiazine derivative with histamine H1-blocking, antimuscarinic, and sedative properties. It is used as an antiallergic, in pruritus, for motion sickness and sedation, and also in animals.
promethazine : A tertiary amine that is a substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropan-2-amine moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Promethazine (PMZ) is an FDA-approved antihistaminergic drug that was identified as a potentially neuroprotective compound in the NINDS screening program." | 1.33 | Promethazine protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. ( Beal, MF; Calingasan, NY; Chen, J; Cleren, C; Lorenzo, BJ; Starkov, AA, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| TOLAN, EJ | 1 |
| OLARIU, J | 1 |
| GERSTENBRAND, F | 1 |
| PATEISKY, K | 1 |
| STJEAN, A | 1 |
| DONALD, M | 1 |
| BAN, TA | 1 |
| BOVET, D | 1 |
| DUREL, P | 1 |
| LONGO, V | 1 |
| WINTHER, K | 1 |
| Cleren, C | 1 |
| Starkov, AA | 1 |
| Calingasan, NY | 1 |
| Lorenzo, BJ | 1 |
| Chen, J | 1 |
| Beal, MF | 1 |
6 other studies available for promethazine and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Treatment of parkinsonism; preliminary report on use of promethazine in 12 cases.
Topics: Humans; Parkinson Disease; Parkinsonian Disorders; Promethazine | 1957 |
[CONTRIBUTION TO THE THERAPY AND REHABILITATION OF PARKINSON'S SYNDROME].
Topics: Histamine H1 Antagonists; Neurosurgery; Orphenadrine; Parasympatholytics; Parkinson Disease; Parkins | 1963 |
INTERCHANGEABLITY OF ANTIPARKINSONIAN MEDICATION.
Topics: Antiparkinson Agents; Biomedical Research; Extrapyramidal Tracts; Geriatrics; Humans; Parasympatholy | 1964 |
[Antagonism of dibenzothiazine derivatives (diparcol, parsidol, phenergan) towards the central effects of nicotine; correspondence with clinical experimentation in Parkinson's disease].
Topics: Empirical Research; Histamine Antagonists; Nicotine; Parkinson Disease; Parkinsonian Disorders; Phen | 1950 |
[Treatment of paralysis agitans with some new preparations: parpanit, diparcol, and phenergan].
Topics: Cyclopentanes; Histamine; Parkinson Disease; Parkinsonian Disorders; Phenothiazines; Promethazine | 1950 |
Promethazine protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Calcium; Calcium Signaling; Disease Models, Animal; Dopamine; | 2005 |